| Gregory Barczak, DPM | |
|
W180n7950 Town Hall Rd, Menomonee Falls, WI 53051-4049 | |
| (252) 255-2500 | |
| Not Available |
| Full Name | Gregory Barczak |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 34 Years |
| Location | W180n7950 Town Hall Rd, Menomonee Falls, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235101478 | NPI | - | NPPES |
| 43214900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 635 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc | 3678760063 | 1040 |
News Archive
The coronavirus pandemic's life-altering effects are likely to result in lasting physical and mental health consequences for many people-particularly those from vulnerable populations-a new study led by the Yale School of Public Health finds.
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease.
› Verified 6 days ago
| Provider Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
The coronavirus pandemic's life-altering effects are likely to result in lasting physical and mental health consequences for many people-particularly those from vulnerable populations-a new study led by the Yale School of Public Health finds.
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Barczak, DPM W180n7950 Town Hall Rd, Menomonee Falls, WI 53051-4049 Ph: (252) 255-2500 | Gregory Barczak, DPM W180n7950 Town Hall Rd, Menomonee Falls, WI 53051-4049 Ph: (252) 255-2500 |
News Archive
The coronavirus pandemic's life-altering effects are likely to result in lasting physical and mental health consequences for many people-particularly those from vulnerable populations-a new study led by the Yale School of Public Health finds.
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease.
› Verified 6 days ago
John L. Schlenz, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 Phone: 262-251-7500 Fax: 262-251-7128 | |
Dr. Priya P Patel, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: N49w15485 Orchid Ct, Menomonee Falls, WI 53051 Phone: 847-638-3435 | |
Todd G. Greenfield, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 Phone: 262-251-7500 Fax: 262-251-7128 |